About this Journal Submit a Manuscript Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 685739, 11 pages
http://dx.doi.org/10.1155/2012/685739
Research Article

Microglial Amyloid- 饾湻 1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer’s Disease

1Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan
2Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan
3Department of Neurology, Mie University, Graduate School of Medicine, Tsu 514-8507, Japan
4Department of Neurology, School of Medicine, Sapporo Medical University, S1W16, Chuo-ku, Sapporo 060-8543, Japan

Received 30 November 2011; Accepted 24 February 2012

Academic Editor: Akio Suzumura

Copyright 漏 2012 Kazuyuki Takata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • Stephanie Busch, Liang Wu, Yuxi Feng, Norbert Gretz, Sigrid Hoffmann, and Hans-Peter Hammes, “Alzheimer's Disease and Retinal Neurodegeneration Share a Consistent Stress Response of the Neurovascular Unit,” Cellular Physiology And Biochemistry, vol. 30, no. 6, pp. 1436–1443, 2012. View at PublisherView at Google Scholar
  • Antero Salminen, Kai Kaarniranta, Anu Kauppinen, Johanna Ojala, Annakaisa Haapasalo, Hilkka Soininen, and Mikko Hiltunen, “Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome,” Progress in Neurobiology, 2013. View at PublisherView at Google Scholar
  • Jessica F. Jordão, Emmanuel Thévenot, Kelly Markham-Coultes, Tiffany Scarcelli, Ying-Qi Weng, Kristiana Xhima, Meaghan O'Reilly, Yuexi Huang, JoAnne McLaurin, Kullervo Hynynen, and Isabelle Aubert, “Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound,” Experimental Neurology, 2013. View at PublisherView at Google Scholar
  • Domenica Musumeci, Giovanni N. Roviello, and Daniela Montesarchio, “An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies,” Pharmacology & Therapeutics, 2013. View at PublisherView at Google Scholar
  • Kazuyuki Takata, “Molecular targeting and translational research for new therapeutic strategies on Alzheimer's disease,” Yakugaku Zasshi, vol. 133, no. 12, pp. 1389–1399, 2013. View at PublisherView at Google Scholar
  • Rui Kang, Ruochan Chen, Qiuhong Zhang, Wen Hou, Sha Wu, Lizhi Cao, Jin Huang, Yan Yu, Xue-gong Fan, Zhengwen Yan, Xiaofang Sun, Haichao Wang, Qingde Wang, Allan Tsung, Timothy R. Billiar, Herbert J. Zeh, Michael T. Lotze, and Daolin Tang, “HMGB1 in Health and Disease,” Molecular Aspects of Medicine, 2014. View at PublisherView at Google Scholar
  • V. Kh. Khavinson, Kuznik, Tarnovskaya, and Linkova, “Peptides and CCL11 and HMGB1 as molecular markers of aging: Literature review and own data,” Advances in Gerontology, vol. 5, no. 3, pp. 133–140, 2015. View at PublisherView at Google Scholar
  • Jong-Jer Lee, Pei-Wen Wang, I-Hui Yang, Chia-Lin Wu, and Jiin-Haur Chuang, “Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5,” The International Journal of Biochemistry & Cell Biology, 2015. View at PublisherView at Google Scholar
  • Judyta K. Juranek, Gurdip K. Daffu, Joanna Wojtkiewicz, David Lacomis, Julia Kofler, and Ann Marie Schmidt, “Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis,” Frontiers in Cellular Neuroscience, vol. 9, 2015. View at PublisherView at Google Scholar
  • Barry W. Festoff, Ravi K. Sajja, Patrick van Dreden, and Luca Cucullo, “HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease,” Journal of Neuroinflammation, vol. 13, no. 1, 2016. View at PublisherView at Google Scholar
  • Kyota Fujita, Kazumi Motoki, Kazuhiko Tagawa, Xigui Chen, Hiroshi Hama, Kazuyuki Nakajima, Hidenori Homma, Takuya Tamura, Hirohisa Watanabe, Masahisa Katsuno, Chiemi Matsumi, Masunori Kajikawa, Takashi Saito, Takaomi Saido, Gen Sobue, Atsushi Miyawaki, and Hitoshi Okazawa, “HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease,” Scientific Reports, vol. 6, pp. 31895, 2016. View at PublisherView at Google Scholar
  • Peter Teismann, Walter Maetzler, Petros Stathakos, Heather L. Martin, Markus A. Hobert, Thomas Gasser, John V. Forrester, Matteo Santoro, Kevin J. Tracey, Gernot Riedel, Tim W. Rattay, and Daniela Berg, “In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin,” Neurobiology of Disease, vol. 91, pp. 59–68, 2016. View at PublisherView at Google Scholar
  • Fan Su, Feng Bai, Hong Zhou, and Zhijun Zhang, “Reprint of: Microglial toll-like receptors and Alzheimer's disease,” Brain, Behavior, and Immunity, vol. 55, pp. 166–178, 2016. View at PublisherView at Google Scholar
  • Fan Su, Feng Bai, Hong Zhou, and Zhijun Zhang, “Microglial toll-like receptors and Alzheimer's disease,” Brain, Behavior, and Immunity, vol. 52, pp. 187–198, 2016. View at PublisherView at Google Scholar
  • Naotoshi Iwahara, Shin Hisahara, Jun Kawamata, Akihiro Matsumura, Kazuki Yokokawa, Taro Saito, Mai Fujikura, Tatsuo Manabe, Hiromi Suzuki, Takashi Matsushita, Syuuichirou Suzuki, and Shun Shimohama, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice,” Journal of Alzheimer's Disease, vol. 55, no. 3, pp. 1235–1247, 2016. View at PublisherView at Google Scholar
  • Xiuling Wang, Hong Zhang, Jian Liu, Rong Chen, Yong Tang, Haixia Chen, Li Gu, Mao Li, Shousong Cao, Dalian Qin, and Jianming Wu, “Inhibitory Effect of Lychee Seed Saponins on Apoptosis Induced by Aβ25-35 through Regulation of the Apoptotic and NF-κB Pathways in PC12 Cells,” Nutrients, vol. 9, no. 4, pp. 337, 2017. View at PublisherView at Google Scholar
  • Yong-Jie Lian, Chun-Lei Jiang, Yun-Xia Wang, Hong Gong, Teng-Yun Wu, Wen-Jun Su, Yi Zhang, Yuan-Yuan Yang, Wei Peng, Ting Zhang, and Jiang-Rui Zhou, “Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1,” Brain, Behavior, and Immunity, vol. 59, pp. 322–332, 2017. View at PublisherView at Google Scholar
  • Jinsha Huang, Jiaolong Yang, Yan Shen, Haiyang Jiang, Chao Han, Guoxin Zhang, Ling Liu, Xiaoyun Xu, Jie Li, Zhicheng Lin, Nian Xiong, Zhentao Zhang, Jing Xiong, and Tao Wang, “HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at PublisherView at Google Scholar
  • Mariagrazia Grilli, and Valeria Bortolotto, “Every cloud has a silver lining: Proneurogenic effects of Aβ oligomers and HMGB-1 via activation of the RAGE-NF-κB axis,” CNS and Neurological Disorders - Drug Targets, vol. 16, no. 3, 2017. View at PublisherView at Google Scholar